Searched for
ADVANCED BREAST CANCER
AstraZeneca's breast cancer drug fails in late-stage trialAstraZeneca's breast cancer drug Etcamah did not meet its main goal in a late-stage trial. The drug showed only a numerical improvement whe...- Biocon shares rise 3% after Rs 638-crore block deal; Active Pine likely sellerBiocon shares rose after a block deal involving around 1.65 crore shares. Investor Active Pine was reportedly looking to sell up to 1.66 cr...
- Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block dealActive Pine is likely to sell up to 1.66 crore Biocon shares, worth Rs 638 crore, through a block deal at Rs 385 per share. The development...
- Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in BrazilBiocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis re...
- Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drugIn a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its colla...
- Quote of the day by Paul McCartney: “Life is quite mysterious and quite miraculous. Every time I come to...” — Inspiring life lessons on creativity, wonder, intuition, passion, joy, and why trusting the unknown can unlock the magic within by the legendary Beatles songwriter and musicianQuote of the Day by Paul McCartney: “Life is quite mysterious and quite miraculous.” In his famous quote, Paul McCartney explores the delic...
- Long-term investing: One reason is good enough, and a must, to own a business. 8 stocks with an upside potential of up to 36%In today’s world, investors cannot assume that correlations that worked in the past will work in exactly the same manner now. We are in a p...
- Delhi HC seeks response on Natco's patent challenge pleaThe Delhi High Court is reviewing Natco Pharma's challenge to a breast cancer drug patent. Natco alleges Novartis and Astex secured two pat...
- Time to re-look at a not-so-glamorous part of healthcare ecosystem: 4 diagnostics stocks with upside potential of up to 18%When companies from a sector with a clear growth path get listed, too much money flows into them, sending valuations high. What follows is ...
- Andhra Pradesh teams up with AstraZeneca for next-gen cancer care modelAndhra Pradesh signed an MoU with AstraZeneca for an integrated precision oncology ecosystem. This initiative will integrate artificial int...
- 'Star Trek' star William Shatner, 95, reveals he & his daughter fought separate stage 4 cancers together: 'It changed my life'William Shatner and his daughter Melanie Shatner shared their Stage 4 cancer diagnoses. Melanie battled breast cancer while William faced m...
- Cancer is not painful in early stages. Doctor shares signs of cancer many dismiss as common cold or indigestion: ‘Your body gives you…’Subtle bodily signals often go unnoticed as early cancer warnings. Blood in stool may indicate hemorrhoids or colorectal cancer, requiring ...
- India developing indigenous solutions to global health challenges: Rajnath SinghIndia is setting new benchmarks in medical research and indigenous solutions. Gene therapy and nuclear medicine are key areas of advancemen...
- Less invasive oral cancer treatment: New IISc Bengaluru study finds ultrasound selectively kills tumor cells while sparing healthy onesNew IISc Bengaluru study: Researchers at the Indian Institute of Science have found that low-frequency ultrasound can selectively kill oral...
- Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection testZydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through ...
- Breakthrough Cancer test allows more Breast Cancer patients to skip ChemotherapyA new genetic test called MammaPrint is helping many breast cancer patients. This test determines the risk of cancer recurrence. Women with...
- Sanofi trial failure ends development of breast cancer treatment amcenestrantA trial dubbed AMEERA-5, which was testing amcenestrant on women with newly-diagnosed advanced breast cancer, was stopped early because an ...
- Apollo Cancer Centres launches breast cancer detection test in tie up with Datar Cancer GeneticsThe EasyCheck- Breast test developed by Nashik-based molecular diagnostics company Datar Cancer Genetics, has received breakthrough designa...
- Zydus Cadila gets USFDA nod for breast cancer treatment drugFulvestrant injection is used alone or in combination with other drugs to treat a certain type of hormone receptor positive, advanced breas...
- Roche files for Avastin to treat breast cancer in EuropeSwiss drugmaker Roche has filed its Avastin drug for use in previously untreated advanced breast cancer in Europe, the company said on Mond...
Load More
